Holen Sie sich die Stockscreener-App
12.83
0.39%
0.05
Handel nachbörslich:
12.30
-0.53
-4.13%
Schlusskurs vom Vortag:
$12.78
Offen:
$12.49
24-Stunden-Volumen:
11,219
Relative Volume:
0.64
Marktkapitalisierung:
$60.23M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-24.77M
KGV:
-17.58
EPS:
-0.73
Netto-Cashflow:
$-17.36M
1W Leistung:
+8.54%
1M Leistung:
+7.36%
6M Leistung:
-30.87%
1J Leistung:
+45.15%
1-Tages-Spanne:
$12.49
$12.83
1-Wochen-Bereich:
$11.56
$12.83
52-Wochen-Spanne:
$4.5601
$76.00
Mink Therapeutics Inc Stock (INKT) Company Profile
Firmenname
Mink Therapeutics Inc
Sektor
Branche
Telefon
212-994-8250
Adresse
149 FIFTH AVENUE, NEW YORK
Vergleichen Sie INKT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INKT
Mink Therapeutics Inc
|
12.83 | 59.99M | 0 | -24.77M | -17.36M | -0.73 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.17 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.25 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
864.42 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
354.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
336.16 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Mink Therapeutics Inc Stock (INKT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-15 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2025-07-14 | Herabstufung | William Blair | Outperform → Mkt Perform |
Mink Therapeutics Inc Aktie (INKT) Neueste Nachrichten
Agenus (AGEN) Q2 2025 Earnings Call Transcript - The Globe and Mail
MiNK Therapeutics, Inc. (NASDAQ:INKT) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
MiNK Therapeutics, Inc. (NASDAQ:INKT) Receives Consensus Recommendation of “Hold” from Analysts - Defense World
Wall Street Zen Upgrades MiNK Therapeutics (NASDAQ:INKT) to “Hold” - Defense World
Gains Recap: Is Orfa Corp America Preferred Security a stock for growth or value investorsJuly 2025 Levels & Real-Time Market Sentiment Alerts - baoquankhu1.vn
Wall Street Zen Upgrades MiNK Therapeutics (NASDAQ:INKT) to "Hold" - MarketBeat
(INKT) Volatility Zones as Tactical Triggers - Stock Traders Daily
Decliners Report: Can MiNK Therapeutics Inc maintain its current growth rate2025 Biggest Moves & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
Wall Street Recap: Is MiNK Therapeutics Inc forming bullish engulfing patternsWeekly Risk Summary & Low Volatility Stock Suggestions - baoquankhu1.vn
MiNK Therapeutics announces board resignation amid public appointment - MSN
Market Outlook: Why MiNK Therapeutics Inc stock attracts high net worth investorsQuarterly Portfolio Summary & Precise Trade Entry Recommendations - Bộ Nội Vụ
MiNK Therapeutics (NASDAQ:INKT) Downgraded by Wall Street Zen to "Sell" - MarketBeat
Why MiNK Therapeutics Inc. stock remains on watchlists2025 Volume Leaders & Safe Entry Point Alerts - Улправда
How MiNK Therapeutics Inc. (6Q40) stock trades under stagflationWeekly Market Report & Consistent Growth Equity Picks - ulpravda.ru
How MiNK Therapeutics Inc. stock valuations compare to rivalsQuarterly Market Summary & Free Verified High Yield Trade Plans - Улправда
Why MiNK Therapeutics Inc. stock attracts global investorsShort Setup & Target Return Focused Stock Picks - Улправда
Can MiNK Therapeutics Inc. (6Q40) stock sustain breakout momentum2025 Geopolitical Influence & Reliable Price Action Trade Plans - Улправда
How MiNK Therapeutics Inc. (6Q40) stock behaves under inflation pressureJuly 2025 Analyst Calls & Growth Focused Stock Pick Reports - ulpravda.ru
MiNK Therapeutics to begin phase 1 trial of iNKT cell therapy for GvHD - Investing.com Australia
MiNK Therapeutics and University of Wisconsin-Madison Announce Phase 1 Clinical Trial of Allo-iNKT Cell Therapy (AgenT-797) to Evaluate Prevention of Graft-Versus-Host Disease - The Manila Times
MiNK Therapeutics and University of Wisconsin–Madison - GlobeNewswire
MiNK Therapeutics and University of Wisconsin-Madison Announce Phase 1 Clinical Trial of Allo-iNKT Cell Therapy to Evaluate Prevention of Graft-Versus-Host Disease - Investing News Network
MiNK Therapeutics announces reverse stock split - MSN
Agenus unit, MiNK surges after peer-reviewed data for lead drug - MSN
Will MiNK Therapeutics Inc. stock reach all time highs in 2025Currency Fluctuation Impact & Learn What Analysts Rate “Strong Buy” - Улправда
Price-Driven Insight from (INKT) for Rule-Based Strategy - Stock Traders Daily
MiNK Therapeutics (NASDAQ:INKT) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Treasury Yields: How MiNK Therapeutics Inc 6Q40 stock responds to job market shiftsDay Trade & Real-Time Volume Triggers - moha.gov.vn
Risk Report: Will MiNK Therapeutics Inc 6Q40 stock enhance shareholder valueWeekly Trade Review & Precise Trade Entry Recommendations - moha.gov.vn
The Technical Signals Behind (INKT) That Institutions Follow - Stock Traders Daily
MiNK Therapeutics, Inc. (NASDAQ:INKT) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
MiNK Therapeutics, Inc. (NASDAQ:INKT) Receives Consensus Rating of “Hold” from Analysts - Defense World
MiNK Therapeutics, Inc. Financial Statements – GETTEX:6Q40 - TradingView — Track All Markets
Published on: 2025-12-21 01:45:03 - Улправда
Signal Recap: Why MiNK Therapeutics Inc. (6Q40) stock could rally strongly2025 Geopolitical Influence & Safe Entry Zone Identification - moha.gov.vn
Wall Street Zen Downgrades MiNK Therapeutics (NASDAQ:INKT) to Sell - Defense World
Can MiNK Therapeutics Inc. stock deliver consistent earnings growth2025 AllTime Highs & Free Growth Oriented Trading Recommendations - Улправда
Published on: 2025-12-20 10:06:06 - Улправда
Total debt per share of MiNK Therapeutics, Inc. – MUN:6Q40 - TradingView — Track All Markets
Why MiNK Therapeutics Inc. stock is seen as undervaluedJuly 2025 Sector Moves & AI Based Trade Execution Alerts - Улправда
Is MiNK Therapeutics Inc. stock in correction or buying zone2025 Price Action Summary & Free High Return Stock Watch Alerts - Улправда
Will MiNK Therapeutics Inc. stock split again soonWeekly Investment Recap & Accurate Entry/Exit Alerts - DonanımHaber
Why MiNK Therapeutics Inc. (6Q40) stock could rally stronglyJuly 2025 Gainers & Real-Time Buy Signal Notifications - DonanımHaber
Published on: 2025-12-19 08:39:05 - Улправда
Trading Systems Reacting to (INKT) Volatility - Stock Traders Daily
Bond Watch: Is MiNK Therapeutics Inc. stock in correction or buying zoneJuly 2025 Update & Community Consensus Trade Signals - BỘ NỘI VỤ
Why MiNK Therapeutics Inc. stock is favored by top institutionsWeekly Trading Summary & Community Verified Trade Signals - Newser
How Mink Therapeutics Inc. (INKT) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Finanzdaten der Mink Therapeutics Inc-Aktie (INKT)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.09%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):